Overview

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of resveratrol in treating patients with colorectal cancer that can be removed by surgery. Resveratrol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Resveratrol